Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Statin and Ezetimibe Association on Chylomicron Kinetics in CHD
NCT00481351Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ezetimibe in coronary heart disease (CHD) (2 arms), sponsored by Universidade de São Paulo. Primary endpoints: Cholesteryl Ester Fractional Clearance Rate at 6 weeks and Low Density Lipoprotein Cholesterol at 12 weeks. Started Jun 2007; status: completed.
02
Drugs
ezetimibe
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00481351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481351.